Twist Bioscience: Fiscal Q4 Earnings Snapshot - Yahoo Finance

5 days ago · SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth …

CouponFollow Extension

$34
OFF

Twist Bioscience: Fiscal Q4 Earnings Snapshot - Yahoo Finance

6 days from now

5 days ago · SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth …

yahoo.com

27%
OFF

Twist Bioscience Corp (TWST) Q4 2024 Earnings Call ... - Yahoo …

6 days from now

4 days ago · In This Article: Revenue: $84.7 million for Q4, a 27% increase year-over-year; $313 million for fiscal 2024, a 28% increase over fiscal 2023. Gross Margin: 45.1% for Q4; 42.6% …

yahoo.com

$51
OFF

Twist Bioscience: Fiscal Q4 Earnings Snapshot | AP News

6 days from now

Nov 18, 2022 · SOUTH SAN FRANCISCO, Calif. (AP) _ Twist Bioscience Corp. (TWST) on Friday reported a loss of $51.1 million in its fiscal fourth quarter. The South San Francisco, …

apnews.com

$31
OFF

Twist Bioscience: Fiscal 4Q Earnings Snapshot - Yahoo

6 days from now

Dec 11, 2019 · SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Wednesday reported a loss of $31.2 million in its fiscal fourth quarter. On a per-share basis, the San Francisco …

yahoo.com

$34
OFF

Twist Bioscience: Fiscal Q4 Earnings Snapshot - Times Union

6 days from now

5 days ago · SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth …

timesunion.com

$0.59
OFF

Earnings Snapshot: Twist Bioscience Tops FQ4 Estimates; Initiates …

6 days from now

More on Twist Bioscience Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy' Twist Bioscience GAAP EPS of -$0.59 beats by $0.11, revenue of $84.71M beats by …

msn.com

18%
OFF

Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates

6 days from now

5 days ago · Twist Bioscience (TWST) delivered earnings and revenue surprises of 19.18% and 2.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to …

yahoo.com

$34
OFF

Twist Bioscience: Fiscal Q4 Earnings Snapshot - The Washington Post

6 days from now

5 days ago · SOUTH SAN FRANCISCO, Calif. — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth …

washingtonpost.com

$52
OFF

Twist Bioscience Price Target Lowered To $52 From $55 At Barclays

6 days from now

4 days ago · Barclays lowered the firm’s price target on Twist Bioscience (TWST) to $52 from $55 and keeps an Overweight rating on the shares. The company reported a solid quarter with a …

yahoo.com

FAQs about Twist Bioscience: Fiscal Q4 Earnings Snapshot - Yahoo Finance Coupon?

What did Twist Bioscience (Twst) do in fiscal 2024?

SOUTH SAN FRANCISCO, Calif., November 18, 2024 -- (BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the fourth quarter and full year fiscal 2024 ended September 30, 2024. ...

What happened to twist BioScience Corp?

SOUTH SAN FRANCISCO, Calif. — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 59 cents. Get a curated selection of 10 of our best stories in your inbox every weekend. ...

What is Twist Bioscience's revenue?

For the current quarter ending in December, Twist Bioscience said it expects revenue in the range of $54 million. The company expects full-year revenue in the range of $261 million to $269 million. ...

Is Twist Bioscience (Twst) a good stock to buy?

Barclays lowered the firm’s price targeton Twist Bioscience (TWST) to $52 from $55 and keeps an Overweight rating on the shares. The company reported a solid quarter with a fiscal 2025 guide better than expectations despite a tough budgetary macro environment, the analyst tells investors in a research note. ...

What is the consensus EPS estimate for Twist Bioscience (Twst)?

The current consensus EPS estimate is -$0.70 on $83.75 million in revenues for the coming quarter and -$2.56 on $376.02 million in revenues for the current fiscal year. Twist Bioscience (TWST) delivered earnings and revenue surprises of 19.18% and 2.59%, respectively, for the quarter ended September 2024. ...

Should you buy Twist Bioscience (twist) ahead of earnings release?

Ahead of this earnings release, the estimate revisions trend for Twist Bioscience: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. ...